相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Contemporary Role of Systematic Prostate Biopsies: Indications, Techniques, and Implications for Patient Care
Osamu Ukimura et al.
EUROPEAN UROLOGY (2013)
The Role of Sarcosine Metabolism in Prostate Cancer Progression
Amjad P. Khan et al.
NEOPLASIA (2013)
Cancer Statistics, 2012
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
Metabolic Profiling, a Noninvasive Approach for the Detection of Experimental Colorectal Neoplasia
David C. Montrose et al.
CANCER PREVENTION RESEARCH (2012)
Changes in Initial Treatment for Prostate Cancer Among Medicare Beneficiaries, 1999-2007
Michaela A. Dinan et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Serum sarcosine increases the accuracy of prostate cancer detection in patients with total serum PSA less than 4.0?ng/ml
Giuseppe Lucarelli et al.
PROSTATE (2012)
Cancer detection and biopsy classification using concurrent histopathological and metabolomic analysis of core biopsies
Meredith V. Brown et al.
GENOME MEDICINE (2012)
Screening for Prostate Cancer: A Review of the Evidence for the US Preventive Services Task Force
Roger Chou et al.
ANNALS OF INTERNAL MEDICINE (2011)
The Tumor Suppressor Activity of the Transmembrane Protein with Epidermal Growth Factor and Two Follistatin Motifs 2 (TMEFF2) Correlates with Its Ability to Modulate Sarcosine Levels
Xiaofei Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Active Surveillance for Prostate Cancer: Progress and Promise
Matthew R. Cooperberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Global proteomics and metabolomics in cancer biomarker discovery
Haleem J. Issaq et al.
JOURNAL OF SEPARATION SCIENCE (2011)
Is sarcosine a biomarker for prostate cancer?
Haleem J. Issaq et al.
JOURNAL OF SEPARATION SCIENCE (2011)
Sarcosine in Prostate Cancer Tissue is Not a Differential Metabolite for Prostate Cancer Aggressiveness and Biochemical Progression
Florian Jentzmik et al.
JOURNAL OF UROLOGY (2011)
Predicting 15-Year Prostate Cancer Specific Mortality After Radical Prostatectomy
Scott E. Eggener et al.
JOURNAL OF UROLOGY (2011)
Magnetic Resonance Imaging/Ultrasound Fusion Guided Prostate Biopsy Improves Cancer Detection Following Transrectal Ultrasound Biopsy and Correlates With Multiparametric Magnetic Resonance Imaging
Peter A. Pinto et al.
JOURNAL OF UROLOGY (2011)
The important role of glycine N-methyltransferase in the carcinogenesis and progression of prostate cancer
Yoo Hyun Song et al.
MODERN PATHOLOGY (2011)
Sarcosine induces increase in HER2/neu expression in androgen-dependent prostate cancer cells
Malin Dahl et al.
MOLECULAR BIOLOGY REPORTS (2011)
SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression
Zhihu Ding et al.
NATURE (2011)
Urine Metabolomic Analysis Identifies Potential Biomarkers and Pathogenic Pathways in Kidney Cancer
Kyoungmi Kim et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2011)
Serum Methionine Metabolites Are Risk Factors for Metastatic Prostate Cancer Progression
Sally Stabler et al.
PLOS ONE (2011)
Efforts to resolve the contradictions in early diagnosis of prostate cancer: a comparison of different algorithms of sarcosine in urine
D-L Cao et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2011)
Urine TMPRSS2:ERG Fusion Transcript Stratifies Prostate Cancer Risk in Men with Elevated Serum PSA
Scott A. Tomlins et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Application of metabolomics to prostate cancer
Bruce J. Trock
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2011)
Sarcosine in Urine after Digital Rectal Examination Fails as a Marker in Prostate Cancer Detection and Identification of Aggressive Tumours
Florian Jentzmik et al.
EUROPEAN UROLOGY (2010)
Metabolomic profiling can predict which humans will develop liver dysfunction when deprived of dietary choline
Wei Sha et al.
FASEB JOURNAL (2010)
Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations
Stefan Gross et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Metabolomic Characterization of Human Prostate Cancer Bone Metastases Reveals Increased Levels of Cholesterol
Elin Thysell et al.
PLOS ONE (2010)
Organization of GC/MS and LC/MS metabolomics data into chemical libraries
Corey D DeHaven et al.
Journal of Cheminformatics (2010)
Serum sarcosine is not a marker for prostate cancer
Eduard A. Struys et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2010)
Integrated, Nontargeted Ultrahigh Performance Liquid Chromatography/Electrospray Ionization Tandem Mass Spectrometry Platform for the Identification and Relative Quantification of the Small-Molecule Complement of Biological Systems
Anne M. Evans et al.
ANALYTICAL CHEMISTRY (2009)
Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression
Arun Sreekumar et al.
NATURE (2009)
Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1α
Shimin Zhao et al.
SCIENCE (2009)
Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy gleason score (Partin tables) based on cases from 2000 to 2005
Danil V. Makarov et al.
UROLOGY (2007)
Genome-wide association study of prostate cancer identifies a second risk locus at 8q24
Meredith Yeager et al.
NATURE GENETICS (2007)
Multiple regions within 8q24 independently affect risk for prostate cancer
Christopher A. Haiman et al.
NATURE GENETICS (2007)
High incidence of prostate cancer detected by saturation biopsy after previous negative biopsy series
Jochen Walz et al.
EUROPEAN UROLOGY (2006)
A combined genomewide linkage scan of 1,233 families for prostate cancer-susceptibility genes conducted by the international consortium for prostate cancer genetics
JF Xu et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2005)
20-year outcomes following conservative management of clinically localized prostate cancer
PC Albertsen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma
JI Epstein et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2005)
Prostate cancer detection with office based saturation biopsy in a repeat biopsy population
JC Rabets et al.
JOURNAL OF UROLOGY (2004)
Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer
M Han et al.
JOURNAL OF UROLOGY (2003)
分享论文
